Stephen Dow Insider Profile
4 Followers
Stephen Dow, Director at Cytokinetics, holds 282.19K shares in Alder Biopharmaceuticals (Ticker: ALDR), holds 338.07K shares in Citrix Systems (Ticker: CTXS), holds 1.57M shares in Cytokinetics (Ticker: CYTK). Most recently, Stephen Dow Bought ― shares of Alder Biopharmaceuticals on Jul 18, 2017 for an estimated value of $250.00K.
Stephen Dow's Trading History
| ALDRAlder Biopharmaceuticals | Jul 18, 2017 | ― | Informative Buy | 250.00K | $5.33M | |
| CTXSCitrix Systems | Jun 03, 2015 | ― | Uninformative Buy | ― | $35.13M | |
| CYTKCytokinetics | Nov 16, 2012 | Director | Informative Sell | 1.06M | $87.90M | |
| TNGOTangoe Inc | Feb 01, 2012 | ― | Uninformative Buy | ― | $137.81K |
You May Also Like
Stephen Dow insider profile FAQ
What is the percentage of profitable transactions made by Stephen Dow?
The percentage of profitable transactions made by Stephen Dow is 100%.
What is the average return per transaction made by Stephen Dow?
The average return per transaction made by Stephen Dow is 35.00%.
What stocks does Stephen Dow hold?
Stephen Dow holds: CYTK, CTXS, ALDR, TNGO stocks.
What was Stephen Dow’s latest transaction?
Stephen Dow’s latest transaction was an Informative Buy of $250.00K.
What was Stephen Dow's most profitable transaction?
Stephen Dow’s most profitable transaction was an Informative Buy of ALDR stock on July 18, 2017. The return on the trade was 60.10%.
What is Stephen Dow's role in Cytokinetics?
Stephen Dow's role in Cytokinetics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
